Bullfrog AI (BFRG) Competitors $2.85 -0.31 (-9.81%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.86 +0.00 (+0.18%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BFRG vs. COYA, TCRX, CRDL, JMAC, EPRX, SAVA, DERM, VIGL, PROC, and CLYMShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Coya Therapeutics (COYA), TScan Therapeutics (TCRX), Cardiol Therapeutics (CRDL), Maxpro Capital Acquisition (JMAC), Eupraxia Pharmaceuticals (EPRX), Cassava Sciences (SAVA), Journey Medical (DERM), Vigil Neuroscience (VIGL), Procaps Group (PROC), and Climb Bio (CLYM). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Coya Therapeutics TScan Therapeutics Cardiol Therapeutics Maxpro Capital Acquisition Eupraxia Pharmaceuticals Cassava Sciences Journey Medical Vigil Neuroscience Procaps Group Climb Bio Bullfrog AI (NASDAQ:BFRG) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment. Is BFRG or COYA more profitable? Coya Therapeutics' return on equity of -31.63% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -141.39% -124.63% Coya Therapeutics N/A -31.63%-27.76% Do analysts recommend BFRG or COYA? Coya Therapeutics has a consensus target price of $16.25, indicating a potential upside of 153.51%. Given Coya Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Coya Therapeutics is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in BFRG or COYA? 1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 39.8% of Coya Therapeutics shares are owned by institutional investors. 33.9% of Bullfrog AI shares are owned by insiders. Comparatively, 12.0% of Coya Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, BFRG or COYA? Bullfrog AI has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Does the MarketBeat Community favor BFRG or COYA? Coya Therapeutics received 19 more outperform votes than Bullfrog AI when rated by MarketBeat users. CompanyUnderperformOutperformBullfrog AIN/AN/ACoya TherapeuticsOutperform Votes1995.00% Underperform Votes15.00% Which has better valuation & earnings, BFRG or COYA? Bullfrog AI has higher earnings, but lower revenue than Coya Therapeutics. Coya Therapeutics is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K413.73-$5.36M-$0.85-3.35Coya Therapeutics$6M17.85-$7.99M-$0.65-9.86 Does the media prefer BFRG or COYA? In the previous week, Bullfrog AI had 2 more articles in the media than Coya Therapeutics. MarketBeat recorded 2 mentions for Bullfrog AI and 0 mentions for Coya Therapeutics. Coya Therapeutics' average media sentiment score of 0.00 beat Bullfrog AI's score of -0.30 indicating that Coya Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Bullfrog AI Neutral Coya Therapeutics Neutral SummaryCoya Therapeutics beats Bullfrog AI on 11 of the 16 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.82M$7.04B$5.78B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-3.356.1326.4618.82Price / Sales413.73312.32457.0180.76Price / CashN/A67.8344.0437.47Price / Book6.636.747.634.64Net Income-$5.36M$138.11M$3.18B$245.69M7 Day Performance-21.92%-2.02%-1.82%-2.63%1 Month Performance21.79%-1.54%0.22%-2.37%1 Year Performance-32.14%-3.14%17.49%13.65% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.2511 of 5 stars$2.85-9.8%N/A-32.1%$24.82M$60,000.00-3.354COYACoya Therapeutics1.4436 of 5 stars$6.88+0.7%$16.25+136.2%-26.3%$114.97M$6M-10.586TCRXTScan Therapeutics2.4626 of 5 stars$2.14-1.8%$11.25+425.7%-68.8%$114.21M$21.05M-2.02100CRDLCardiol Therapeutics2.8825 of 5 stars$1.37+1.5%$8.40+513.1%-18.4%$113.18MN/A-3.5120News CoverageJMACMaxpro Capital AcquisitionN/A$8.35+0.6%N/A+1,067.4%$112.12MN/A0.002,021EPRXEupraxia Pharmaceuticals3.2218 of 5 stars$3.14-2.1%$9.00+186.5%N/A$111.88MN/A-4.3629Analyst ForecastShort Interest ↓News CoverageHigh Trading VolumeSAVACassava Sciences3.7729 of 5 stars$2.32+2.2%$111.50+4,706.0%-88.5%$111.62MN/A-1.6830Upcoming EarningsDERMJourney Medical2.5229 of 5 stars$5.24+5.0%$9.38+78.9%+38.0%$109.46M$79.18M-5.5790VIGLVigil Neuroscience3.1918 of 5 stars$2.65+0.4%$19.75+645.3%+0.3%$108.33MN/A-1.2940PROCProcaps GroupN/A$0.95-40.3%N/A-73.4%$107.18M$409.92M0.004,900News CoverageGap DownHigh Trading VolumeCLYMClimb Bio2.4906 of 5 stars$1.58-6.0%$10.00+532.9%N/A$106.21MN/A-0.749Gap Up Related Companies and Tools Related Companies Coya Therapeutics Competitors TScan Therapeutics Competitors Cardiol Therapeutics Competitors Maxpro Capital Acquisition Competitors Eupraxia Pharmaceuticals Competitors Cassava Sciences Competitors Journey Medical Competitors Vigil Neuroscience Competitors Procaps Group Competitors Climb Bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BFRG) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BFRG Stock Alerts